title: Carotenoids and prostate cancer risk.
abstract: Chemoprevention is presumably one of most effective means to combat prostate cancer (PCa). Patients usually require more than a decade to develop a clinically significant Pca, therefore, an ideal target for chemoprevention. This review will focus on recent findings of a group of naturally occurring chemicals, carotenoids, for potential use in reducing PCa risk.
authors.affiliation: Urology Research, Mayo Clinic, Rochester, MN 55905, USA. young.charles@mayo.edu
authors.forename: C Y F
authors.initials: CY
authors.lastname: Young
authors.forename: H-Q
authors.initials: HQ
authors.lastname: Yuan
authors.forename: M-L
authors.initials: ML
authors.lastname: He
authors.forename: J-Y
authors.initials: JY
authors.lastname: Zhang
mesh_terms: D000975:Antioxidants / Q000737:chemistry / Q000627:therapeutic use; D002338:Carotenoids / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000517:prevention & control*; D012307:Risk Factors
chemical_list: D000975:Antioxidants; D002338:Carotenoids